0001062993-22-005779.txt : 20220225
0001062993-22-005779.hdr.sgml : 20220225
20220225171023
ACCESSION NUMBER: 0001062993-22-005779
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220223
FILED AS OF DATE: 20220225
DATE AS OF CHANGE: 20220225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenhalgh Ellis Skott
CENTRAL INDEX KEY: 0001790671
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39130
FILM NUMBER: 22681768
MAIL ADDRESS:
STREET 1: C/O TELA BIO, INC.
STREET 2: 1 GREAT VALLEY PARKWAY, SUITE 24
CITY: MALVERN
STATE: PA
ZIP: 19355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TELA Bio, Inc.
CENTRAL INDEX KEY: 0001561921
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 455320061
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 484-320-2930
MAIL ADDRESS:
STREET 1: 1 GREAT VALLEY PARKWAY, SUITE 24
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-02-23
0001561921
TELA Bio, Inc.
TELA
0001790671
Greenhalgh Ellis Skott
C/O TELA BIO, INC.
1 GREAT VALLEY PARKWAY, SUITE 24
MALVERN
PA
19355
0
1
0
0
Chief Technology Officer
Common Stock
2022-02-23
4
A
0
3900
0
A
28799
D
Stock Option (Right to Buy)
11.75
2022-02-23
4
A
0
6675
0
A
2032-02-23
Common Stock
6675
6675
D
These restricted stock units will vest in four equal annual installments beginning on February 23, 2023, subject to the Reporting Person's continuous service through the applicable vesting dates.
The option vests 25% on February 23, 2023, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.
/s/ Megan Smeykal, Attorney-in-fact
2022-02-25